88 citations · 89 across the 5 of their papers we have counts for
5 papers
A Complete Characterisation of Structured Missingness
James Jackson, Robin Mitra, Niels Hagenbuch +2
Our capacity to process large complex data sources is ever-increasing, providing us with new, important applied research questions to address, such as how to handle missing values…
Anonymising Clinical Data for Secondary Use
Irene Ferreira, Chris Harbron, Alex Hughes +2
Secondary use of data already collected in clinical studies has become more and more popular in recent years, with the commitment of the pharmaceutical industry and many academic i…
The use of external controls: To what extent can it currently be recommended?
Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron +4
With more and better clinical data being captured outside of clinical studies and greater data sharing of clinical studies, external controls may become a more attractive alternati…
A multi-arm multi-stage platform design that allows pre-planned addition of arms while still controlling the family-wise error
Peter Greenstreet, Thomas Jaki, Alun Bedding +2
There is growing interest in platform trials that allow for adding of new treatment arms as the trial progresses as well as being able to stop treatments part way through the trial…
A meta-analytic framework to adjust for bias in external control studies
Devin Incerti, Michael T Bretscher, Ray Lin +1
While randomized controlled trials (RCTs) are the gold standard for estimating treatment effects in medical research, there is increasing use of and interest in using real-world da…